Remove Biopharma Remove FDA Remove Side effects Remove Training
article thumbnail

Drug repurposing, real world data and AI/ML: perspectives and opportunities

Clarivate

Drug candidates have a high rate of failure, as only 10% of de-novo drugs put through clinical trials finally obtain market approval, with the highest rate of attrition occurring at phase I and II of clinical trials (assessing safety, tolerability, dosage, efficacy, and side effects). For example, in the U.S.,

article thumbnail

How to Work with Patient Advocates, Influencers, and Ambassadors

PM360

Be clear in your governance documents and training to level set expectations. For example, everyone must be steeped in both FDA and FTC guidelines. Regardless of the tactics and strategies employed, I would encourage more biopharma professionals to get personally involved in patient engagement programs.

article thumbnail

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Medgadget

Interestingly, due to FDA’s regulatory methodology, surgical robots have to be approved for specific indications by the agency. Moreover, the required training to get proficient with the device is only a few hours, unlike two weeks or more for the da Vinci.